Jiangsu Hansoh Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd., explained in plain language.
-
Oral pill trial offers new hope for controlling rare blood disease
Disease control Recruiting nowThis study is testing a new oral medication called HS-10542 for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare disease where the immune system destroys red blood cells. The goal is to see if the pill can safely control the disease and improve blood counts, especial…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for Tough-to-Treat lung cancer: first human trial begins
Disease control Recruiting nowThis is an early-stage study testing a new oral medication called HS-10504 for people with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change (EGFR C797S mutation) and has worsened after previous targeted treatments. The main goals are to find a safe d…
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC